Litigation Details for ELI LILLY AND COMPANY v. NANG KUANG PHARMACEUTICAL CO., LTD. (S.D. Ind. 2014)
✉ Email this page to a colleague
ELI LILLY AND COMPANY v. NANG KUANG PHARMACEUTICAL CO., LTD. (S.D. Ind. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-10-08 |
| Court | District Court, S.D. Indiana | Date Terminated | 2016-07-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Tanya Walton Pratt |
| Jury Demand | Defendant | Referred To | |
| Patents | 7,772,209 | ||
| Link to Docket | External link to docket | ||
Details for ELI LILLY AND COMPANY v. NANG KUANG PHARMACEUTICAL CO., LTD. (S.D. Ind. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-10-08 | 1 | expiration of U.S. Patent Nos. 5,344,932 (“the ’932 patent”) and 7,772,209 (“the ’209 patent”). ALIMTA ® is… (Infringement of U.S. Patent No. 7,772,209) 33. Plaintiffs incorporate…Attachments: # 1 Exhibit A - '932 Patent, # 2 Exhibit B - '209 Patent, # 3 Civil Cover Sheet, # 4 Proposed… 1. This is an action for patent infringement under the patent laws of the United States, Title…. The ’932 patent is attached as Exhibit A hereto. 14. The ’209 patent, titled “Antifolate | External link to document | |
| 2016-07-01 | 119 | Defendants infringe Lilly’s U.S. Patent No. 7,772,209 (“the ’209 patent”) based on the filing of Abbreviated…claims of the ’209 patent with the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office…of the ’209 patent. Defendants have also all alleged that the claims of the ’209 patent are invalid. …the ’209 patent were invalid and that the defendants in that action infringed the ’209 patent. That action… 1. This is a consolidated action for patent infringement. Lilly has alleged that each of | External link to document | |
| 2015-08-24 | 59 | claims of U.S. Patent Nos. 5,344,932 (the “‘932 patent”) and 7,772,209 (the “‘209 patent”) are invalid… I. BACKGROUND This Hatch-Waxman patent infringement case arises from Nang Kuang’s submission…offer for sale of the ANDA Products. The ‘932 patent is owned by the Trustees of Princeton University…covers Lilly’s anti-cancer drug pemetrexed. The ‘209 patent is owned by Lilly and is directed to methods …folic acid and vitamin B 12. Lilly sells the patented drug and its associated method of administration | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
